Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study.

Sandra Rajme-López Bernardo Alfonso Martínez-GuerraJessica Zalapa-SotoCarla Marina Roman-Montes Karla Maria Tamez-Torres Maria Fernanda Gonzalez-LaraThierry Hernandez-GilosulDavid Kershenobich-StalnikowitzJosé Sifuentes-OsornioAlfredo Ponce-de-LeónGuillermo M Ruíz-Palacios

Published in: Open forum infectious diseases (2022)

Early outpatient treatment with remdesivir significantly reduces hospitalization or death by 84% in high-risk, majority immunosuppressed patients with Omicron variant COVID-19.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
chronic kidney disease
ejection fraction
prognostic factors
combination therapy
patient reported outcomes
respiratory syndrome coronavirus
replacement therapy
smoking cessation